Search
Exploiting a vulnerability in an aggressive leukemia affecting babies
- OPACC
- Jun 2, 2022
- 1 min read
New work finds that the cells that cause relapse in MLL-rearranged B-ALL can morph between two states, and that targeting one of these states might curb the cancer.
Recent Posts
See AllWhile the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...
Comments